期刊
NATURE NANOTECHNOLOGY
卷 12, 期 4, 页码 322-328出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/NNANO.2016.260
关键词
-
资金
- French National research Agency (ANR) as part of the Investissement d'Avenir programme IDEX Paris-Saclay [ANR-11-IDEX- 0003-02]
- ANR
- Ministry of Science and Technology (Taiwan) [ANR-2010-INTB-1002]
- ANR through Eranet Euronanomed project [2011-ERNA-006]
- Fondation Jerome Lejeune
- European Union FP7-Health AgedBrainSysBio grant [305299]
- Region Ile-de-France [12018592]
- CNRS Programme Interdisciplinaire
- Triangle de la Physique [2012-038T]
Brain diseases such as autism and Alzheimer's disease (each inflicting >1% of the world population) involve a large network of genes displaying subtle changes in their expression(1). Abnormalities in intraneuronal transport have been linked to genetic risk factors found in patients(2,3), suggesting the relevance of measuring this key biological process. However, current techniques are not sensitive enough to detect minor abnormalities. Here we report a sensitive method to measure the changes in intraneuronal transport induced by brain-disease-related genetic risk factors using fluorescent nanodiamonds (FNDs). We show that the high brightness, photostability and absence of cytotoxicity(4) allow FNDs to be tracked inside the branches of dissociated neurons with a spatial resolution of 12 nm and a temporal resolution of 50 ms. As proof of principle, we applied the FND tracking assay on two transgenic mouse lines that mimic the slight changes in protein concentration (similar to 30%) found in the brains of patients. In both cases, we show that the FND assay is sufficiently sensitive to detect these changes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据